Roche’s audio webcast replay on efficacy and safety of risdiplam in patients with type 2/3 spinal muscular atrophy presented at SMA Europe 2020

Roche has hosted a live audio webcast and conference call on Thursday, 6 February 2020.

Agenda

  • Welcome
    Karl Mahler, Head of Investor Relations
  • Phase II/III SUNFISH part 2 data - efficacy and safety of risdiplam in patients with type 2 or type 3 SMA
    Paulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development
  • Q&A

Please register to access the webcast replay.

* Mandatory

 

The registration form for the webcast is not available.

 

Please come back 30 minutes before the webcast start date and fill in the registration form.